Horizon Pharma PLC (HZNP) Insider Trading
- $7,441,631.45
- $442,242,882.98
- Jan. 17, 2023
- Timothy P Walbert
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 17, 2023 | EVP | 27,129 | $113.03 | Sell | $3,066,390.87 | |
| Jan. 13, 2023 | CFO | 36,148 | $113.17 | Sell | $4,090,869.16 | |
| Jan. 10, 2023 | EVP | 3,368 | $113.05 | Sell | $380,752.40 | |
| Jan. 6, 2023 | EVP | 5,187 | $113.29 | Sell | $587,635.23 | |
| Dec. 12, 2022 | EVP | 28,352 | $111.45 | Sell | $3,159,830.40 | |
| Aug. 4, 2022 | EVP | 745 | $66.67 | Buy | $49,669.15 | |
| July 29, 2022 | EVP | 4,850 | $82.57 | Sell | $400,464.50 | |
| July 19, 2022 | EVP | 90 | $85.04 | Sell | $7,653.60 | |
| July 7, 2022 | EVP | 82 | $85.01 | Sell | $6,970.82 | |
| July 7, 2022 | EVP, Research & Development | 82 | $85.01 | Sell | $6,970.82 | |
| June 3, 2022 | CEO | 25,000 | $92.34 | Sell | $2,308,500.00 | |
| May 31, 2022 | CEO | 25,000 | $92.48 | Sell | $2,312,000.00 | |
| May 20, 2022 | CEO | 25,000 | $90.00 | Sell | $2,250,000.00 | |
| May 11, 2022 | CEO | 17,600 | $90.00 | Sell | $1,584,000.00 | |
| May 6, 2022 | CEO | 7,400 | $90.86 | Sell | $672,364.00 | |
| April 22, 2022 | CEO | 25,000 | $106.59 | Sell | $2,664,750.00 | |
| April 20, 2022 | CFO | 50,000 | $114.71 | Sell | $5,735,500.00 | |
| April 12, 2022 | EVP | 20,214 | $113.12 | Sell | $2,286,607.68 | |
| April 8, 2022 | CEO | 25,000 | $112.38 | Sell | $2,809,500.00 | |
| April 6, 2022 | EVP | 42,009 | $110.02 | Sell | $4,621,830.18 | |
| April 6, 2022 | CFO | 215,335 | $110.01 | Sell | $23,689,003.35 | |
| March 30, 2022 | CEO | 50,000 | $105.26 | Sell | $5,263,000.00 | |
| March 25, 2022 | CEO | 25,000 | $109.37 | Sell | $2,734,250.00 | |
| March 25, 2022 | CFO | 663 | $110.00 | Sell | $72,930.00 | |
| March 23, 2022 | CFO | 26,090 | $110.00 | Sell | $2,869,900.00 | |
| March 11, 2022 | CEO | 25,000 | $100.93 | Sell | $2,523,250.00 | |
| Feb. 18, 2022 | EVP | 1,313 | $94.82 | Sell | $124,498.66 | |
| Feb. 11, 2022 | CEO | 25,000 | $97.41 | Sell | $2,435,250.00 | |
| Jan. 31, 2022 | CEO | 100,000 | $91.85 | Sell | $9,185,000.00 | |
| Jan. 28, 2022 | CEO | 25,000 | $90.00 | Sell | $2,250,000.00 | |
| Jan. 14, 2022 | CEO | 25,000 | $90.02 | Sell | $2,250,500.00 | |
| Jan. 6, 2022 | EVP | 7,987 | $99.57 | Sell | $795,265.59 | |
| Dec. 28, 2021 | CFO | 8,575 | $110.00 | Sell | $943,250.00 | |
| Dec. 7, 2021 | EVP | 1,525 | $100.00 | Sell | $152,500.00 | |
| Nov. 30, 2021 | CEO | 50,000 | $102.40 | Sell | $5,120,000.00 | |
| Nov. 4, 2021 | EVP | 30,168 | $113.04 | Sell | $3,410,190.72 | |
| Nov. 1, 2021 | CEO | 25,000 | $118.49 | Sell | $2,962,250.00 | |
| Sept. 30, 2021 | CEO | 50,000 | $110.30 | Sell | $5,515,000.00 | |
| Sept. 21, 2021 | EVP | 46,271 | $110.00 | Sell | $5,089,810.00 | |
| Sept. 17, 2021 | EVP | 28,143 | $107.91 | Sell | $3,036,911.13 | |
| Sept. 9, 2021 | EVP | 23,250 | $107.84 | Sell | $2,507,280.00 | |
| Aug. 5, 2021 | EVP | 7,542 | $106.34 | Sell | $802,016.28 | |
| July 30, 2021 | CEO | 25,000 | $101.74 | Sell | $2,543,500.00 | |
| July 22, 2021 | Director | 5,000 | $100.04 | Sell | $500,200.00 | |
| July 8, 2021 | EVP | 35,076 | $92.54 | Sell | $3,245,933.04 | |
| May 14, 2021 | CFO | 102,925 | $90.01 | Sell | $9,264,279.25 | |
| May 10, 2021 | Director | 20,000 | $86.56 | Sell | $1,731,200.00 | |
| April 30, 2021 | CEO | 25,000 | $94.98 | Sell | $2,374,500.00 | |
| April 12, 2021 | Director | 15,000 | $90.28 | Sell | $1,354,200.00 | |
| April 12, 2021 | EVP | 65,613 | $88.96 | Sell | $5,836,932.48 |
Insiders are both buying and selling Horizon Pharma PLC stock.
The insider traders at Horizon Pharma PLC are: Timothy P Walbert, Jeffrey W Sherman, Paul W Hoelscher, Brian K Beeler, Andy Pasternak, Michael G Grey, Jeff Kent, Michael A Desjardin, Miles W Mchugh, Vikram Karnani, Geoffrey M Curtis, Irina Konstantinovsky, Barry Moze, Brian K. Beeler, Timothy P. Walbert, Elizabeth H.Z. Thompson, Jeff Himawan, Paul W. Hoelscher, Jeffrey Bird, Virinder Nohria, Todd Smith, Daniel A Camardo, Timothy Walbert, Jeffrey W. Sherman, William F Daniel, Balaji Venkataraman, James Samuel Shannon, Jeffrey W Bird, Robert Carey, Sean M Clayton, Thompson Elizabeth H.Z., Vaere Robert De, Vaere Robert J De, and Aaron Cox
The most active insider trader at Horizon Pharma PLC is Timothy P Walbert with 28 trades.
Balaji Venkataraman has sold the most Horizon Pharma PLC stock with a total value of $140,486,967.56.
Jeffrey Bird has bought the most Horizon Pharma PLC stock with a total value of $9,635,544.36.
The most recent insider trade for Horizon Pharma PLC was on Jan. 17, 2023.
The single biggest insider buy for Horizon Pharma PLC was from Jeffrey Bird with a total value of $4,346,374.50 on Dec. 13, 2013.
The single biggest insider sell for Horizon Pharma PLC was from Balaji Venkataraman with a total value of $70,243,483.78 on Nov. 13, 2014.